A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
Rain moving east, will spread across Wales in the first half of the night, some likely heavy.
Rain moving east, heavy at times
The Lesbian, Gay, Bisexual and Transgendered communities in Cardiff are celebrating 30 years of campaigning; as part of LGBT History Month.